Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets 94.65M
Total Liability 86.63M
Assets-to-Libability Ratio 1.09
Total Current Assets 81.34M
Total Current Liability 15.16M
Current Ratio 5.37
Quick Ratio 4.48
Debt to Equity Ratio 7.66
Income Statement Metrics
Net Income -36.08M
EPS -0.93
EBITA -28.67M
Gross Profit 33.44M
Gross Profit Margin -33.97%
Operating Margin -17.02%
Net Profit Margin -79.85%
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float 21.15M
Shares Short 227.95K
% Short 0.0141%
% Insider 3.383%
% Institutions 61.729%
News

Profile

Neuropace Inc (NPCE)

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides Physician Tablet, Patient Data Management System, and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Exchange: NASDAQ

IPO Date: 4/22/2021

Sector: Healthcare

Industry: Medical Devices

Employees: 184

Address: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043

https://www.neuropace.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202409/30/202406/30/202403/31/202412/31/202309/30/202306/30/202303/31/202312/31/202209/30/2022Totals
Assets
94.65K96.30K94.39K98.85K107.65K99.30K102.23K106.27K114.11K120.47K1.81M
Current Assets
81.34K82.59K80.23K84.25K92.72K83.97K86.51K90.16K97.71K104.37K1.64M
Cash And Short Term Investments
52.76K56.83K55.54K58.95K66.45K61.35K63.57K67.61K77.41K85.41K1.14M
Net Receivables
12.85K11.56K11.24K11.63K12.31K11.28K10.88K9.19K7.48K7.88K161.84K
Inventory
13.38K12.08K11.36K11.42K11.21K9.76K10.01K10.75K9.71K8.58K160.70K
Other Current Assets
2.35K2.12K2.08K2.26K2.74K1.59K2.05K2.60K3.11K2.50K135.87K
Non Current Assets
13.31K13.71K14.16K14.60K14.93K15.33K15.72K16.11K16.39K16.10K169.72K
Property Plant Equipment
------9761.02K1.06K-6.05K
Long Term Investments
-----------
Non Currrent Assets Other
413425524401.9994024814874783681438.59K
Liabilities
86.63K86.48K84.50K84.51K87.00K82.94K81.01K78.78K79.33K77.06K1.55M
Current Liabilities
15.16K14.78K12.59K13.11K16.23K12.81K11.51K9.88K10.98K9.42K195.90K
Accounts Payable
2.95K2.16K2.29K3.27K2.33K1.21K1.81K1.83K2.15K1.18K30.93K
Short Long Term Debt
----------5.63K
Other Current Liabilities
9.79K6.47K5.71K7.29K9.45K10.04K8.18K6.58K7.41K7.55K120.11K
Non Current Liabilities
71.48K71.70K71.92K71.40K70.77K70.12K69.50K68.91K68.35K67.65K1.35M
Long Term Debt
------54.85K53.86K--307.32K
Other Liabilities
----------5.02K
Stockholder Equity
8.01K9.82K9.88K14.34K20.65K16.36K21.23K27.49K34.78K43.41K261.32K
Preferred Stock Equity
-----------
Liabilities And Stockholders Equity
94.65K96.30K94.39K98.85K107.65K99.30K102.23K106.27K114.11K120.47K1.75M
Common Equity
------262525-172
Retained Earnings
-------490.35K-481.23K-470.85K--3.52M
Totals559.72K563.34K550.81K575.14K622.50K575.84K152.43K176.59K173.63K672.20K660.89K329.61K314.94K412.32K446.48K123.73K390.32K---7.30M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202412/31/202312/31/202212/31/202112/31/202012/31/2019Totals
Assets
94.65K107.65K114.11K133.56K55.95K21.09K527.01K
Current Assets
81.34K92.72K97.71K132.82K54.56K20.26K479.41K
Cash And Short Term Investments
52.76K66.45K77.41K115.58K38.08K5.09K355.37K
Net Receivables
12.85K12.31K7.48K7.09K8.39K6.02K54.15K
Inventory
13.38K11.21K9.71K7.82K6.91K7.90K56.94K
Other Current Assets
2.35K2.74K3.11K4.54K1.18K1.25K15.17K
Non Current Assets
13.31K14.93K16.39K7461.39K83547.60K
Property Plant Equipment
--1.06K6035158102.99K
Non Currrent Assets Other
41352436821507251.86K
Liabilities
86.63K87.00K79.33K60.06K203.78K150.44K667.25K
Current Liabilities
15.16K16.23K10.98K9.30K9.60K75.15K136.41K
Accounts Payable
2.95K2.33K2.15K1.38K94990310.66K
Short Long Term Debt
----2.04K62.80K64.84K
Other Current Liabilities
9.79K11.18K6.00K7.92K6.60K4.72K46.21K
Non Current Liabilities
71.48K70.77K68.35K50.76K194.19K75.30K530.84K
Other Liabilities
---9111.57K1.73K4.21K
Stockholder Equity
8.01K20.65K34.78K73.50K-147.83K-129.35K-140.24K
Liabilities And Stockholders Equity
94.65K107.65K114.11K133.56K55.95K21.09K527.01K
Common Equity
--2524--49
Retained Earnings
---470.85K-423.77K---894.62K
Totals559.72K624.36K172.22K316.43K494.34K326.07K2.49M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;06/30/202203/31/202212/31/202109/30/202106/30/202103/31/202112/31/202009/30/202006/30/202003/31/2020Totals
Revenue
10.20K11.37K11.00K10.34K12.63K11.22K10.75K12.77K7.64K9.97K107.89K
Cost Of Revenue
2.73K3.12K2.92K2.83K3.27K2.72K2.53K3.20K2.22K2.92K28.46K
Gross Profit
7.47K8.26K8.08K7.51K9.36K8.49K8.22K9.57K5.42K7.06K79.43K
Operating Expenses
18.44K18.02K43.42K13.75K13.96K12.37K13.73K10.74K8.87K12.52K165.82K
Selling General Administrative
-12.77K-12.44K-11.75K-9.42K9.53K8.27K7.28K7.05K5.62K7.68K-960
Research Development
5.67K5.58K13.88K4.33K4.44K4.10K3.92K3.69K3.25K4.83K53.69K
Other Operating Expenses
21.17K21.14K52.34K16.58K17.23K15.09K-13.94K11.09K15.43K184.01K
Operating Income
-10.97K-9.76K-9.02K-6.24K-4.61K-3.87K-2.98K-1.17K-3.45K-5.46K-57.52K
Net Interest Income
-1.63K-1.70K-1.41K-1.83K-1.87K-1.85K-1.84K-2.79K-3.81K-3.00K-21.73K
Interest Income
221134186-------541
Interest Expense
1.85K1.83K1.86K1.83K1.87K1.85K1.88K2.79K3.81K3.00K22.58K
Other Income Expense Net
-1.72K-1.70K-12.34K-1.84K-3.89K-4.94K205-2.96K5.35K1.28K-22.55K
Income Before Tax
-12.69K-11.46K-36.08K-8.08K-8.49K-8.81K-4.62K-4.13K-8.79K-6.74K-109.90K
Tax Provision
-----------
NetIncome
-12.69K-11.46K-36.08K-8.08K-8.49K-8.81K-4.62K-4.13K-8.79K-6.74K-109.90K
NetIncome Applicable To Common Shares
-12.69K-11.46K-10.69K-8.08K-8.49K-8.81K--3.90K-8.79K-6.74K-79.66K
Ebit
-10.84K-9.63K-8.83K-6.26K-6.62K-6.96K--1.33K-4.98K-5.46K-60.91K
Basic EPS
--0.47-0.44-0.34-0.48-32.73-----34.459999999999994
Totals-8.24K-169.477.48K7.33K29.83K20.03K34.47K43.35K14.64K30.56K179.26K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202112/31/202012/31/2019Totals
Revenue
45.18K41.14K36.97K123.29K
Cost Of Revenue
11.75K10.87K10.51K33.12K
Gross Profit
33.44K30.27K26.46K90.17K
Operating Expenses
57.17K43.32K48.49K148.99K
Selling General Administrative
-38.96K27.63K30.20K18.87K
Research Development
18.21K15.70K18.29K52.20K
Other Operating Expenses
68.92K54.19K59.00K182.11K
Operating Income
-23.74K-13.05K-22.03K-58.82K
Net Interest Income
-6.96K-11.45K-9.22K-27.63K
Interest Income
44841261750
Interest Expense
-7.41K11.49K9.48K13.56K
Other Income Expense Net
-12.34K-11.23K-7.94K-31.51K
Income Before Tax
-36.08K-24.28K-29.97K-90.33K
Tax Provision
----
NetIncome
-36.08K-24.28K-29.97K-90.33K
NetIncome Applicable To Common Shares
-36.08K-24.05K-29.97K-90.10K
Ebit
-28.67K-12.79K-20.49K-61.95K
Basic EPS
-33.99---33.99
Totals8.76K113.52K90.08K212.36K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202409/30/202406/30/202403/31/202412/31/202309/30/202306/30/202303/31/202312/31/202209/30/2022Totals
Cash From Operating Activities
-4.80K-1.72K-3.90K-7.53K-3.34K-2.30K-4.36K-9.70K-7.84K-6.97K-120.70K
Net Income
-5.25K-5.45K-7.51K-8.93K-6.20K-7.26K-9.12K-10.38K-11.15K-11.79K-192.92K
Depreciation
4514514444234093984033957527397.04K
Extraordinary Items
-----------
Change Receivables
-------1.68K-1.71K---3.48K
Change To Inventory
-1.35K43411-249-1.52K210683-1.07K-1.17K-198-5.47K
Change To Liabilities
------1.58K-1.03K855-3012.21K
Change To Net Income
------3.25K3.63K3.15K3.19K27.18K
ChangeToOperatingActivities
------1.80K1.80K-7477151.67K
Cash flows From Investing Activities
------5.30K10.07K8.90K6.97K-51.99K
Capital Expenditures
-39-100-63-104-32-9--132-102-31-1.60K
Other Cashflows From Investing Activities
-----------
Cash From Financing Activities
8482.90K509728.21K-27195-255-138-8171.39K
Net Borrowings
----------16.26K
Sale Purchase Of Stock
-721-72-649-37-35-41-146-4-107.04K
Dividends Paid
-----------
Other Cashflows From Financing Activities
5032.90K509728.21K-35-41-110-1.03K-8210.44K
Cash And Cash Equivalents Changes
------1.14K115---19.68K
Totals-9.64K126-10.08K-16.89K5.71K-9.06K-898-8.52K-8.52K-7.69K-13.35K-35.83K-47.75K-12.56K234.61K-38.38K-11.52K115.67K-2.14K24.10K147.38K
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;12/31/202412/31/202312/31/202212/31/202112/31/202012/31/2019Totals
Cash From Operating Activities
-17.95K-19.70K-36.87K-24.58K-21.61K-25.03K-145.73K
Net Income
-27.14K-32.96K-47.08K-36.08K-24.28K-29.97K-197.51K
Depreciation
1.77K1.60K2.99K2963124217.39K
Extraordinary Items
-------
Change Receivables
---3911.30K--913
Change To Inventory
251-1.70K-2.13K-1.16K672-1.64K-5.70K
Change To Liabilities
--6321.95K-5-822.50K
Change To Net Income
--10.88K9.77K9322.08K23.66K
ChangeToOperatingActivities
---2.91K-259-3562.48K-1.05K
Cash flows From Investing Activities
--23.80K-85.40K-10.77K3.62K-68.75K
Capital Expenditures
-306-173-603-384-62-468-2.00K
Other Cashflows From Investing Activities
-306------306
Cash From Financing Activities
4.33K8.13K490102.53K55.01K21.37K191.85K
Net Borrowings
----4.09K24.46K21.33K41.70K
Sale Purchase Of Stock
--259-59106.62K--106.30K
Other Cashflows From Financing Activities
1.05K239490-2.47K62.24K42.66K104.20K
Cash And Cash Equivalents Changes
---12.58K-7.45K---20.03K
Totals-38.30K-44.82K-63.35K60.60K86.55K36.76K37.44K